MSI Financial Services’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

MSI Financial Services’s Portfolio CNCR Stock Details CNCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$6K	Buy	305 +115	+61%	+$2.64K	﹤0.01%	3051
2016 Q3	$5K	Hold	190	–	–	﹤0.01%	3118
2016 Q2	$4K	Hold	190	–	–	﹤0.01%	3229
2016 Q1	$4K	Hold	190	–	–	﹤0.01%	3242
2015 Q4	$5K	Buy	+190	New	+$5.47K	﹤0.01%	3065

Other funds holding CNCR

BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BBPWM

Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

MSI Financial Services's CNCR Position: Q4 2016 in Review

MSI Financial Services increased its ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) stake by 61% in Q4 2016, buying an estimated $2.64K and bringing the position to 305 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #3051.

MSI Financial Services first reported a position in CNCR in Q4 2015 and has held it in 5 quarters since. 12 funds tracked by Wall St. Rank hold CNCR as of Q4 2016.

MSI Financial Services held 305 shares of ETF Series Solutions Trust Range Cancer Therapeutics ETF worth $6K as of Q4 2016.
MSI Financial Services bought 115 ETF Series Solutions Trust Range Cancer Therapeutics ETF shares in Q4 2016, an estimated $2.64K.
ETF Series Solutions Trust Range Cancer Therapeutics ETF made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3051 holding.
MSI Financial Services first reported a position in ETF Series Solutions Trust Range Cancer Therapeutics ETF in Q4 2015 and has held it in 5 quarters since.
12 funds tracked by Wall St. Rank held ETF Series Solutions Trust Range Cancer Therapeutics ETF as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.